BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30273818)

  • 1. Development and validation of a method using ultra performance liquid chromatography coupled to tandem mass spectrometry for determination of zoledronic acid concentration in human bone.
    Lo Faro AF; Giorgetti R; Busardò FP; Lodi G; Martini V; Pispero A; Iriti M; Varoni EM
    J Pharm Biomed Anal; 2019 Jan; 162():286-290. PubMed ID: 30273818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of zoledronic acid in murine bone by liquid chromatography coupled with tandem mass spectrometry.
    Raccor BS; Sun J; Lawrence RF; Li L; Zhang H; Somerman MJ; Totah RA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Sep; 935():54-60. PubMed ID: 23954589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid and sensitive method for determination of methylene-diphosphonate in rat bone using liquid chromatography-mass spectrometry.
    Zhang L; Zeng Y; Zeng Y; Hu D; Liu H; Peng R; Liang X; Liu J
    J Pharm Biomed Anal; 2023 Nov; 236():115727. PubMed ID: 37734256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive dental management of osteonecrosis of the jaws related to zoledronic acid treatment.
    Coello-Suanzes JA; Rollon-Ugalde V; Castaño-Seiquer A; Lledo-Villar E; Herce-Lopez J; Infante-Cossio P; Rollon-Mayordomo A
    Oral Dis; 2018 Sep; 24(6):1029-1036. PubMed ID: 29412504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoledronic acid promotes TLR-4-mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw.
    Zhu W; Xu R; Du J; Fu Y; Li S; Zhang P; Liu L; Jiang H
    FASEB J; 2019 Apr; 33(4):5208-5219. PubMed ID: 30624969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of Low Amounts of Zoledronic Acid by HPLC-ESI-MS Analysis: Method Development and Validation.
    Petrovici AR; Silion M; Simionescu N; Kallala R; Pinteala M; Maier SS
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification by energy dispersive x-ray spectroscopy of alendronate in the diseased jaw bone of patients with bisphosphonate-related jaw osteonecrosis.
    Schaudinn C; Gorur A; Webster P; Jones AC; Neely M; Jelliffe RW; Le AD; Sedghizadeh PP
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Oct; 114(4):480-6. PubMed ID: 22986243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication-Related Osteonecrosis of the Jaw.
    Ohta K; Yoshimura H
    Am J Med Sci; 2020 Sep; 360(3):316-317. PubMed ID: 32418608
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy.
    Kastritis E; Melea P; Bagratuni T; Melakopoulos I; Gavriatopoulou M; Roussou M; Migkou M; Eleutherakis-Papaiakovou E; Terpos E; Dimopoulos MA
    Leuk Lymphoma; 2017 Oct; 58(10):2304-2309. PubMed ID: 28604257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for developing osteonecrosis of jaw in advanced cancer patients underwent zoledronic acid treatment.
    Qi WX; Zhao S; Chen J
    Future Oncol; 2019 Oct; 15(30):3503-3511. PubMed ID: 31580147
    [No Abstract]   [Full Text] [Related]  

  • 11. Mesenchymal stromal cells administration for osteonecrosis of the jaw caused by bisphosphonate: report of two cases.
    De Santis GC; de Macedo LD; Orellana MD; Innocentini LMAR; Ferrari TC; Ricz HMA; Caruso SR; Fernandes TR; Covas DT
    Acta Oncol; 2020 Jul; 59(7):789-792. PubMed ID: 32079438
    [No Abstract]   [Full Text] [Related]  

  • 12. Bisphosphonate-related osteonecrosis of the jaws--a case report.
    Kamoh AK; Ogle O
    Compend Contin Educ Dent; 2012 May; 33(5):e74-7. PubMed ID: 23268588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental investigation of relationship between trauma and bisphosphonate-related osteonecrosis.
    Agaçayak KS; Yuksel H; Atilgan S; Koparal M; Uçan MC; Ozgöz M; Yaman F; Atalay Y; Acikan I
    Niger J Clin Pract; 2014; 17(5):559-64. PubMed ID: 25244263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a sensitive solid-phase-extraction (SPE) method using high-performance liquid chromatography/tandem mass spectrometry (LC-MS/MS) for determination of risedronate concentrations in human plasma.
    Ghassabian S; Wright LA; Dejager AD; Smith MT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 881-882():34-41. PubMed ID: 22197608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis?
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Otto S; Pautke C
    J Oral Maxillofac Surg; 2014 May; 72(5):903-10. PubMed ID: 24485975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw.
    Higuchi T; Soga Y; Muro M; Kajizono M; Kitamura Y; Sendo T; Sasaki A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):547-551. PubMed ID: 29574058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive effect of tetrahedral framework nucleic acids on bisphosphonate-related osteonecrosis of the jaw.
    Cui W; Chen X; Zhu J; Zhang M; Xiao D; Qin X; Zhang T; Lin Y
    Nanoscale; 2020 Aug; 12(33):17196-17202. PubMed ID: 32667372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed alveolar bone repair and osteonecrosis associated with Zoledronic Acid therapy in rats: macroscopic, microscopic and molecular analysis.
    Ferreira GZ; Zen Filho EV; Rubira-Bullen IRF; Garlet GP; Santos CF; Santos PSDS
    J Appl Oral Sci; 2020; 28():e20200204. PubMed ID: 32997086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of different doses of zoledronic acid in establishing of bisphosphonate-related osteonecrosis.
    Silva PG; Ferreira Junior AE; Teófilo CR; Barbosa MC; Lima Júnior RC; Sousa FB; Mota MR; Ribeiro Rde A; Alves AP
    Arch Oral Biol; 2015 Sep; 60(9):1237-45. PubMed ID: 26093347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast LC-MS/MS analysis of free oxysterols derived from reactive oxygen species in human plasma and carotid plaque.
    Helmschrodt C; Becker S; Schröter J; Hecht M; Aust G; Thiery J; Ceglarek U
    Clin Chim Acta; 2013 Oct; 425():3-8. PubMed ID: 23827692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.